Johnson & Johnson News

Johnson & Johnson is a global healthcare conglomerate engaged in the research, development, and manufacture of pharmaceuticals, medical devices, and consumer health products. With a mission to improve health for humanity, J&J operates across three segments: Innovative Medicine, focusing on areas like oncology and immunology; MedTech, providing surgical and orthopedic solutions; and Consumer Health, offering products in baby care, skin health, and oral care. The company emphasizes innovation, sustainability, and global health equity, delivering solutions that impact millions worldwide.

www.jnjmedtech.com

01 JUN '23

Written on {{ "2023-06-01T00:00:00+00:00" | date "longDate" }}

INHANCE SHOULDER SYSTEM: A NEW OPTION FOR REVERSE SHOULDER REPLACEMENT SURGERY

The INHANCE Shoulder System empowers surgeons to treat a broad range of cases with a streamlined, comprehensive implant offering that features common instrumentation and unique interoperative flexibility.

Read more…

22 MAY '23

Written on {{ "2023-05-22T00:00:00+00:00" | date "longDate" }}

JANSSEN TO HIGHLIGHT SCIENTIFIC ADVANCES AT ASCO AND EHA

Janssen will also highlight its commitment to transform cancer care with more than 90 presentations showcasing robust, differentiated portfolio and pipeline in hematologic malignancies and solid tumours.

Read more…

05 APR '23

Written on {{ "2023-04-05T00:00:00+00:00" | date "longDate" }}

JOHNSON & JOHNSON'S ERLEADA^® NOW AVAILABLE IN A ONCE-DAILY OPTION

Addition of 240mg strength allows prescribers flexibility to prescribe one 240mg tablet or four 60mg tablets once-daily based on patient needs.

Read more…